EMBL Ventures is an independent venture capital investor based in Heidelberg, Germany, focusing on life science companies across Europe. The firm aims to build companies that create significant commercial opportunities based on new therapeutic treatment modalities, pharmaceuticals, next-generation enabling technology platforms, or innovations in diagnostics and medical devices. EMBL Ventures manages €120 million on behalf of major European institutional and private investors and typically invests as lead or co-lead investor. The firm maintains a close relationship with the European Molecular Biology Laboratory (EMBL) and its technology transfer organization, EMBL Enterprise Management Technology Transfer GmbH (EMBLEM), allowing it to finance disruptive technologies in an entrepreneurial start-up environment.
Is EMBL Ventures the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with EMBL Ventures, along with a list of other relevant VCs, is available on Hopohopo.io.
Stages
Seed, Series A
First ticket size
€1,000,000 - €10,000,000
When approaching EMBL Ventures, founders should highlight the scientific rigor and translational potential of their technology, especially if it leverages cutting-edge research or has clear clinical validation pathways. Demonstrating a strong founding team with deep domain expertise and a clear plan for regulatory and commercial milestones will resonate, as will evidence of robust IP protection. EMBL Ventures values collaborations with academic institutions and a clear vision for how your innovation can address unmet medical needs in a scalable way.
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.